Jan-Philip Kunert

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Prostate Cancer

Staphylococcus Aureus

Positron Emission Tomography

Top Venues

EJNMMI research

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
Synthesis and preclinical evaluation of novel 99m Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI research 13 (1) (2023)
Thomas Günther, Matthias Konrad, León Stopper, Jan-Philip Kunert, Sebastian Fischer, Roswitha Beck, Angela Casini, Hans-Jürgen Wester
Optimization of the Pharmacokinetic Profile of [ 99m Tc]Tc-N 4 -Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Jan-Philip Kunert, Sebastian Fischer, Alexander Wurzer, Hans-Jürgen Wester
Albumin-Mediated Size Exclusion Chromatography: The Apparent Molecular Weight of PSMA Radioligands as Novel Parameter to Estimate Their Blood Clearance Kinetics. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)